Literature DB >> 433465

[Impairment of performance by alcohol and diazepam (author's transl)].

J Lutze, H P Gelbke, G Schmidt.   

Abstract

An investigation was carried out on the effect of the intake of diazepam and alcohol on simple performance tests. The combined administration of diazepam and alcohol led to an increase of the plasma diazepam concentration as compared to that obtained after diazepam without alcohol. Furthermore, after combined intake of diazepam and alcohol a decrease of performance was observed, that was significantly higher, than the effects obtained after either alcohol or diazepam alone. This impairment was especially noticeable duirng the first hour of the experiment, i.e. until the plateau of the diazepam plasma concentration was reached, while afterwards a correlation between diazepam plasma concentration and impairment of performance could not be established. The relevance of these findings for the interpretation of diazepam plasma concentrations in relation to the impairment of performance are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 433465     DOI: 10.1007/bf02092045

Source DB:  PubMed          Journal:  Z Rechtsmed        ISSN: 0044-3433


  25 in total

1.  Plasma concentrations of diazepam and its metabolites after peroral, intramuscular, and rectal administration. Correlation between plasma concentration and sedatory effect of diazepam.

Authors:  J Kanto
Journal:  Int J Clin Pharmacol Biopharm       Date:  1975-12

2.  Blood levels and electroencephalographic effects of diazepam and bromazepam.

Authors:  M Fink; R E Weinfeld; M A Schwartz; A H Conney
Journal:  Clin Pharmacol Ther       Date:  1976-08       Impact factor: 6.875

3.  Reduced concentrations of plasma diazepam in chronic alcoholic patients following an oral administration of diazepam.

Authors:  R Sellman; A Pekkarinen; L Kangas; E Raijola
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975-01

4.  Plasma concentrations of diazepam and of its metabolite N-desmethyldiazepam in relation to anxiolytic effect.

Authors:  H H Dasberg; E van der Kleijn; J P Guelen; H M van Praag
Journal:  Clin Pharmacol Ther       Date:  1974-05       Impact factor: 6.875

5.  Polyethylene glycol as a solvent for diazepam: bioavailability and clinical effects after intramuscular administration, comparison of oral, intramuscular and rectal administration, and precipitation from intravenous solutions.

Authors:  K Korttila; A Sothman; P Andersson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1976-07

6.  Proceedings: Drug interaction on driving skills as evaluated by laboratory tests and by a driving simulator.

Authors:  M Linnoila; M J Mattila
Journal:  Pharmakopsychiatr Neuropsychopharmakol       Date:  1973-03

7.  Plasma levels of diazepam after oral and intramuscular administration.

Authors:  J Kanto
Journal:  Br J Anaesth       Date:  1974-11       Impact factor: 9.166

8.  Radioimmunological screening and gas chromatographic identification of diazepam in blood and serum.

Authors:  H P Gelbke; H J Schlicht; G Schmidt
Journal:  Arch Toxicol       Date:  1977-11-21       Impact factor: 5.153

9.  Neuropsychologic effects of diazepam related to single dose kinetics and liver function.

Authors:  J Hendel; P Elsass; P B Andreasen; E Gymoese; E F Hvidberg
Journal:  Psychopharmacology (Berl)       Date:  1976-07-09       Impact factor: 4.530

10.  The effects of low doses of amylobarbitone sodium and diazepam on human performance.

Authors:  J Hart; H M Hill; C E Bye; R T Wilkinson; A W Peck
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

View more
  2 in total

1.  [Role of drugs in traffic accidents. A pilot study of traffic accident offenders in Switzerland (Bern region)].

Authors:  L Ulrich; O Rudin; A Amsler; P Zink
Journal:  Z Rechtsmed       Date:  1984

2.  Factors influencing the activity and fate of benzodiazepines in the body.

Authors:  E van der Kleijn; T B Vree; A M Baars; R Wijsman; L C Edmunds; H J Knop
Journal:  Br J Clin Pharmacol       Date:  1981       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.